Products
Latest News
FAQ
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
Phase 3
Completed
Conditions
Gastric Cancer
Interventions
Drug: 5-FU plus CDDP
Drug: S-1
Drug: S-1 plus CDDP
Subscribe
First Posted Date
2005-09-20
Last Posted Date
2011-07-07
Lead Sponsor
Taiho Pharmaceutical Co., Ltd.
Target Recruit Count
180
Registration Number
NCT00202969
Locations
🇨🇳
Beijing Cancer Hospital, No.52 Fu-Cheng Road, Hai-dian District, Beijing, China
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy